CNOOC Limited Announced Its 2024 Annual Results
Reserves and Production Reached New Plateau Profit and Dividend Recorded Double-Digit Rise HONG KONG, March 27, 2025 /PRNewswire/ -- CNOOC Limited (the "Company", SEHK: 00883 (HKD Counter) and 80883 (RMB Counter), SSE: 600938) announced today its...
Clarivate Partners with Iprova to Streamline the Invention Creation and Submission Process
The partnership will see Iprova's suite of solutions integrated with IP management software IPfolio LONDON, March 18, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced a...
Asian AI Innovator AICE Shines as First Runner-Up in MWC Global Competition
Launches the First Marketing Deep Dynamic AI System(ADGo)Across Five Key Asian Markets TAIPEI, March 12, 2025 /PRNewswire/ -- The globally renowned Mobile World Congress (MWC) in Barcelona concluded on March 6, 2025. AI technology startup AICE Inc....
Mega Matrix Inc. Announced Seven New English Short Dramas on FlexTV (March 3-7): Rebirth, Suspense & Passionate Romance
SINGAPORE, March 12, 2025 /PRNewswire/ -- Mega Matrix Inc. (NYSE American: MPU)'s global leading short drama platform, FlexTV, launched seven English dramas from March 3 to 7, 2025, spanning genres such as rebirth, romance, suspense, and revenge....
Personetics Pioneers the Cognitive Banking Era With a New Set of AI-Driven Capabilities
Combining financial wellness and needs-based sales for deeper, more loyal customer relationships NEW YORK, March 11, 2025 /PRNewswire/ -- Personetics, the company transforming how financial institutions build and monetize customer relationships,...
Gan & Lee Pharmaceuticals Announced First Participant Dosed in the US Phase 2 Clinical Study of Bofanglutide (GZR18) Injection for Overweight or Obesity
BEIJING and BRIDGEWATER, N.J., March 10, 2025 /PRNewswire/ -- Gan & Lee Pharmaceuticals (Gan & Lee, Shanghai Stock Exchange: 603087) announced that the first participant has been successfully dosed in a Phase 2 clinical trial of bofanglutide...
ASCO GU｜RemeGen Announced Highly Encouraging Data from the Phase II Clinical Trial Evaluating Disitamab Vedotin plus Immunotherapy as Perioperative Regimen for Bladder Cancer
YANTAI, China, Feb. 15, 2025 /PRNewswire/ -- On the morning of February 14, 2025 (UTC-8), at the ongoing 2025 American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU) held in San Francisco, USA, Professor Xinan Sheng from...
Mega Matrix Inc. Announced that the Urban Romance Micro Drama "A flash Marriage With The Billionaire Tycoon" Premiered on FlexTV
SINGAPORE, Feb. 13, 2025 /PRNewswire/ -- Mega Matrix Inc. (NYSE American: MPU)'s globally leading short series streaming platform, FlexTV, has launched a romantic miniseries exploring love, responsibility, and redemption—A flash Marriage With The...
Akeso Announced Enrollment of First Patient in Phase 3 Trial of Cadonilimab for Consolidation Therapy After Concurrent or Sequential Chemoradiotherapy in NSCLC
HONG KONG, Feb. 13, 2025 /PRNewswire/ -- Akeso, Inc. (9926. HK) ("Akeso" or the "Company") announced the recent completion of the first patient enrollment in the Phase 3 randomized, double-blind, multicenter clinical trial (COMPASSION-30/AK104-309)...
NaaS Technology Inc. to Participate in Upcoming Investor Conferences in February 2025
BEIJING, Feb. 12, 2025 /PRNewswire/ -- NaaS Technology Inc. (Nasdaq: NAAS) ("NaaS" or the "Company"), the first U.S.-listed EV charging service company in China, today announced that management will participate in the following upcoming investor...